Klabid 250 mg (Tablet)
Unit Price: ৳ 30.00 (2 x 7: ৳ 420.00)
Strip Price: ৳ 210.00
Medicine Details
Category | Details |
---|---|
Generic | Clarithromycin |
Company | Unimed unihealth pharmaceuticals ltd |
Also available as |
Indications
- Acute bacterial exacerbation of chronic bronchitis in adults
- Acute maxillary sinusitis
- Community-acquired pneumonia
- Pharyngitis or tonsillitis
- Uncomplicated skin and skin structure infections
- Acute otitis media in pediatric patients
- Treatment and prophylaxis of disseminated mycobacterial infections
- Helicobacter pylori infection and duodenal ulcer disease in adults
Pharmacology
- Inhibits microsomal protein synthesis in susceptible organisms
- Binds to the donor site on the 50S subunit of the bacterial ribosome
- Active against most Gram-positive bacteria and Chlamydia
- More acid-stable than Erythromycin
- Twice the activity of Erythromycin against H. influenzae
- Resistance in most species of Gram-negative bacteria
Dosage & Administration
- Dosage varies based on indication and patient age
- Combination dosing regimens for H. pylori infection
- Different dosages in renal and hepatic impairment
Interaction
- Contraindicated with specific medications like HMG-CoA reductase inhibitors, gastroprokinetic agents, ergot alkaloids, antipsychotics, and anti-gout agents
- Not recommended with certain antiarrhythmics drugs
Contraindications
- Hypersensitivity to clarithromycin, erythromycin, or macrolide antibacterial drugs
- History of cholestatic jaundice or hepatic dysfunction associated with the prior use of clarithromycin
Side Effects
- Nausea
- Vomiting
- Diarrhoea
- Abdominal pain
- Stomatitis
- Glossitis
- Headache
- Allergic reactions
- Taste perversion
- Transient central nervous system side effects including anxiety, dizziness, insomnia, and hallucination
Pregnancy & Lactation
- Suitable for use in neonates and children in appropriate doses
- Breast milk from mothers receiving Clarithromycin should not be given to infants until treatment is completed
- Not recommended for pregnant patients
Precautions & Warnings
- Discontinue if severe acute hypersensitivity reactions occur
- Avoid in patients with known QT prolongation or receiving drugs known to prolong the QT interval
- Increased risk of all-cause mortality in patients with coronary artery disease
- Evaluate for Clostridium difficile associated diarrhea if diarrhea occurs
- Exacerbation of myasthenia gravis reported in patients receiving Klabid therapy
Use in Special Populations
- Established safety and effectiveness for various indications in pediatric patients
- Not studied in MAC patients under the age of 20 months
- Safety and effectiveness in pediatric patients under 6 months of age not established
Overdose Effects
- Expected to produce gastrointestinal symptoms in large amounts
- Reported altered mental status, paranoid behavior, hypokalemia, and hypoxemia with ingestion of high doses
- Prompt elimination of unabsorbed drug and supportive measures are recommended
- Serum levels not expected to be appreciably affected by dialysis
Therapeutic Class
- Macrolides
Storage Conditions
- Store in a cool and dry place, protected from light and moisture
- Reconstituted suspension must be used within specified timeframes
- Keep out of reach of children
Related Brands
- Klabid 500 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Klabid ER 500 mg (Tablet (Extended Release)) - unimed-unihealth-pharmaceuticals-ltd
- Klabid 125 mg/5 ml (Powder for Suspension) - unimed-unihealth-pharmaceuticals-ltd
- Maclar 250 mg (Tablet) - techno-drugs-ltd
- Maclar 500 mg (Tablet) - techno-drugs-ltd